
Objective::To analyze the accuracy of the SPOT vision screener in detecting hyperopic reserve in preschool children, and calculate the optimal referral criteria for screening myopia and pre-myopia.Methods::In this cross-sectional study, children who visited the Yuhuatai District Maternal and Child Health Clinic from January 2022 to April 2023 were included consecutively. Refraction was obtained using SPOT and cycloplegic retinoscopy. The data were analyzed using the Wilcoxon signed-rank test and the receiver operating characteristic curves.Results::A total of 812 children (mean age 4.2 ±1.0 years) were included in this study, including 404 boys and 408 girls. Among them, 94 children had myopia (11.6%) and 232 children had pre-myopia (28.6%). SPOT underestimated spherical equivalent (SE) compared to cycloplegic retinoscopy (+0.25 D vs. +1.12 D, Z=-20.22, P<0.001). The optimal referral criterion for screening myopia was ≤-0.50 D, sensitivity 91.49%, specificity 88.58%, Youden index 0.80, and for screening pre-myopia was ≤0 D, sensitivity 69.63%, specificity 81.07%, Youden index 0.51. Conclusions::The SPOT vision screener may underestimate the hyperopic reserve in preschool children. The optimal referral criteria for screening myopia and pre-myopia were ≤-0.50 D and ≤0 D, respectively.
患者,女,7岁,因"戴镜1年后视力矫正不良"于2020年10月在天津市眼科医院就诊。患者曾在2019年6月因视力下降于外院就诊,复方托比卡胺睫状肌麻痹验光示:右眼最佳矫正视力(BCVA)-3.50=0.6,左眼BCVA-2.50+0.50×105°=0.4。诊断:屈光不正。左眼弱视,给予框架眼镜全矫屈光不正联合遮盖治疗。患者戴镜1年,矫正视力无提高。患者无全身疾病、外伤、激光笔照射及视力突然降低史。我院眼科检查示:双眼裸眼视力0.1,角膜映光正位,外眼及眼前节无异常;眼底检查示:左眼黄斑区月牙状瘢痕,边界清晰(图1);光学相干断层扫描血管成像(Optical coherence tomography angiography,OCTA)示:左眼黄斑区色素上皮层隆起,椭圆体带缺失(图2);复方托比卡胺睫状肌麻痹验光示:右眼BCVA-5.00=0.8,左眼BCVA-4.00+0.75×95°=0.4。右眼调节幅度9.50 D,调节灵敏度5 cpm,左眼调节幅度7.50 D,调节灵敏度3 cpm,双眼均为负镜片通过困难。诊断:双眼屈光不正,调节不足,左眼黄斑陈旧病变。给予框架眼镜矫屈光不正,遮盖右眼4 h/d联合海丁格刷(YGS光刷治疗仪,北京同明尚业医疗器械有限责任公司)和红光闪烁(YHY弱视治疗仪,北京同明尚业医疗器械有限责任公司)治疗,以及翻转拍进行视觉训练。患者于2020年12月复查,复方托比卡胺睫状肌麻痹验光示:右眼BCVA-6.50=1.0,左眼BCVA-5.00+1.00×90°=0.6;微视野(MAIA,意大利CenterVue公司)检查示:左眼旁中心注视,注视位点在黄斑鼻上方,注视稳定性较差。2021年3月检查结果:右眼BCVA 1.0,左眼BCVA 0.6;微视野检查示:左眼旁中心注视,注视位点位于黄斑鼻上方,注视稳定性较差。2021年5月检查结果:小瞳验光示右眼BCVA-6.5=1.0,左眼BCVA-5.0+1.0×90°=0.9;微视野检查示左眼黄斑中心凹旁注视点,注视稳定性明显改善(图3B);双眼调节幅度及调节灵敏度均提升至正常,分别为13.50 D和13 cpm,其后间隔3~4个月随访(图3C-D),直至2022年3月,患者左眼BCVA均为0.9,并保持稳定的旁中心注视。
Objective::To compare the effects of bifocal toric intraocular lens (IOL) implantation and standard nontoric bifocal IOL implantation combined with peripheral corneal limbal relaxing incisions (LRI) in cataract patients with moderate preexisting corneal astigmatism.Methods::A prospective non-randomized controlled study was conducted between July 2019 and June 2022 in Fushun Eye Hospital. Totally of 67 patients with corneal astigmatism between 0.75-2.50 diopters (D) who were scheduled for cataract surgery were included. All patients underwent unilateral cataract surgery and based on the voluntary principle, 32 patients underwent ultrasonic emulsification cataract aspiration followed by implantation of AcrySof IQ ReSTOR Toric IOL (ART group), while other 35 patients received AcrySof IQ ReSTOR IOL implantation combined with LRIs (LRIs group). The uncorrected distance visual acuity (UDVA), uncorrected near visual acuity (UNVA), residual astigmatism analysis, contrast sensitivity, reading function, and quality of life were evaluated 3 months after surgery. Reading function was measured using the Radner-Vissum test, and postoperative quality of life was assessed using the National Eye Institute Refractive Error Quality of Life (NEI-RQL) questionnaire. Independent sample t-tests were used to analyze the data. Generalized linear models were used to calculate the scores of NEI-RQL for both groups. Results::Compared with the ART group, the LRIs group had smaller difference vector (0.52±0.45 D vs. 0.79±0.53 D, t=-3.30, P=0.003), magnitude of error (-0.17±0.68 D vs. -0.37±0.74 D, t=5.24, P<0.001), absolute value of angle of error (-3.39±38.62° vs. -2.86±24.71°, t=-2.10, P=0.036), and correction index (0.79±0.71 vs. 0.64±0.73, t=2.04, P=0.045). The success index of the ART group was significantly lower than that of the LRIs group (0.47±0.36 and 0.63±0.49, t=-2.31, P=0.023), while the successful rate of not wearing glasses after surgery was significantly higher than LRIs group (87.49±15.56 and 78.98±16.03, t=2.02, P=0.048). The postoperative comparison between the two groups showed no statistically significant differences in contrast sensitivity (both photopic and scotopic) or reading ability (all P>0.05). Conclusions::Both ART implantation and ReSTOR combined with LRIs can effectively correct patients' astigmatism and address their postoperative need for not wearing glasses. ART implantation showed better efficiency in correcting astigmatism, while the two therapies exhibited comparable efficacy in improving patients' subjective visual quality, especially in terms of near vision.
角膜交联术(Corneal cross-linking,CXL) [1]以核黄素(维生素B 2)作为光敏剂,应用紫外线A(Ultraviolet A,UVA)照射角膜(含扩张区域),诱导角膜基质内部结构形成光化学交联,从而提高角膜生物力学性能。治疗性CXL能够有效阻止或延缓角膜扩张的进展,主要用于治疗圆锥角膜(Keratoconus,KC)、角膜屈光手术后继发角膜扩张等扩张性角膜疾病,近年来已在国内外临床上逐步推广并具有广泛开展的趋势,为了规范CXL的临床应用,保障医疗质量和医疗安全,结合中国实际情况,经过充分讨论达成以下共识,以供临床医师参考使用。
The global incidence of myopia is increasing at an alarming rate, and the World Health Organization (WHO) has listed myopic as one of the blinding eye diseases to be urgently addressed. Myopia is a complex disease with multiple genes and factors interacting with heredity and environment. The treatment of myopia has limited effects and some disadvantages, and there is no consensus on clinical management strategies at present. Risk assessment of myopia to identify the population in need of intervention (such as high-risk factors for myopia, preclinical myopia, early myopia, advanced myopia) is the most important initial step in prevention and control of myopia. The purpose of this review is to provide the latest clinical management strategies for the prevention and control of myopia, address the health problems associated with myopia and alleviate the burden of myopia.